Division of Vascular and Endovascular Surgery, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY.
The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY.
Ann Vasc Surg. 2021 Feb;71:208-214. doi: 10.1016/j.avsg.2020.08.109. Epub 2020 Sep 3.
Traditional practice suggests the abandonment of veins smaller than 3 mm in diameter for arteriovenous fistula (AVF) creation because of a low rate of maturation. This study aims to show that with balloon-assisted maturation (BAM), undersized veins can be used to create functional AVFs with a high rate of success.
All patients who underwent AVF creation between 2014 and 2018 at a tertiary academic medical center were retrospectively reviewed. The patients without preoperative vein mapping, those who failed to follow-up, and the patients who were not on dialysis were excluded. A fistula was considered to be mature if it was successfully cannulated for dialysis. A total of 596 patients were identified for analysis. The cohort was divided into the small-vein group (SVG, <2.5 mm) and large-vein group (LVG, ≥2.5 mm) based on preoperative vein size. Categorical variables were analyzed with the chi-squared test for their association with maturation status. Continuous variables were analyzed with the Wilcoxon rank sum test. A P-value less than 0.05 was considered significant.
In the study cohort, 61.9% of the patients were male, with an average age of 62.8 ± 13.7 years, and an average preoperative vein size of 2.9 ± 1.1 mm. With similar demographic distribution, the participants in the SVG (n = 216) had significantly smaller preoperative vein size of 1.9 ± 0.4 mm than the patients in the LVG (n = 380), 3.5 ± 0.8 mm (P = 0.001). There were significantly more radio-cephalic AVFs created in the SVG (77.8% versus 48.7%, P < 0.0001). The overall maturation rate was 83.1% (n = 495), 219 fistulas (36.7%) matured primarily and 276 (46.3%) required interventions. Ninety-one percent of the patients required only 1 or 2 BAMs to achieve maturation. The SVG achieved a maturation rate of 75.9% as compared with 87.1% in the LVG (P = 0.002). A significantly higher number of patients in the SVG required BAM for maturation as compared with the LVG (67.7% versus 49.9%, P = 0.0002); however, there was no difference in the average number of BAMs required for fistula maturation between the groups (1.5 ± 0.8 for the SVG vs. 1.4 ± 0.7 for the LVG). In multivariable logistic regression analysis, vein size ≥2.5 mm (odds ratio (OR) = 2.11, confidence interval (CI): 1.36-3.27, P = 0.0009) and male sex (OR = 2.30, CI: 1.49-3.57, P = 0.0002) were independent predictors of maturation.
Small veins can be used for AVF creation with lower but still favorable maturation rates using BAM interventions, especially in male patients. This practice can increase the creation of autogenous dialysis access and potentially reduce complications related to prosthetic dialysis access.
传统观点认为,直径小于 3 毫米的静脉不适宜用于动静脉瘘(AVF)的建立,因为其成熟率较低。本研究旨在证明通过球囊辅助成熟(BAM),即使是小静脉也可以用于创建具有高成功率的功能性 AVF。
回顾性分析了 2014 年至 2018 年期间在一家三级学术医疗中心接受 AVF 建立的所有患者。排除了术前无静脉造影、未随访和未接受透析的患者。如果瘘管能够成功进行透析穿刺,则认为其成熟。共确定了 596 名患者进行分析。根据术前静脉大小,将队列分为小静脉组(SVG,<2.5 毫米)和大静脉组(LVG,≥2.5 毫米)。使用卡方检验分析分类变量与成熟状态的关系。使用 Wilcoxon 秩和检验分析连续变量。P 值小于 0.05 被认为具有统计学意义。
在研究队列中,61.9%的患者为男性,平均年龄为 62.8±13.7 岁,平均术前静脉大小为 2.9±1.1 毫米。两组患者的人口统计学分布相似,但 SVG 组(n=216)的患者术前静脉尺寸明显较小,为 1.9±0.4 毫米,而 LVG 组(n=380)为 3.5±0.8 毫米(P=0.001)。SVG 组中桡动脉-头静脉 AVF 的比例明显更高(77.8%对 48.7%,P<0.0001)。总体成熟率为 83.1%(n=495),219 个瘘管(36.7%)主要成熟,276 个(46.3%)需要干预。91%的患者仅需要 1 或 2 次 BAM 即可达到成熟。SVG 的成熟率为 75.9%,而 LVG 为 87.1%(P=0.002)。与 LVG 组相比,SVG 组需要 BAM 以实现成熟的患者比例显著更高(67.7%对 49.9%,P=0.0002);然而,两组患者需要的平均 BAM 数量没有差异(SVG 组为 1.5±0.8,LVG 组为 1.4±0.7)。多变量逻辑回归分析显示,静脉直径≥2.5 毫米(比值比(OR)=2.11,置信区间(CI):1.36-3.27,P=0.0009)和男性(OR=2.30,CI:1.49-3.57,P=0.0002)是成熟的独立预测因素。
使用 BAM 干预措施,小静脉可用于 AVF 的建立,其成熟率虽然较低,但仍然较为理想。这种做法可以增加自体透析通路的建立,并可能减少与人工透析通路相关的并发症。